Health
Pfizer vaccine reduces rate of symptomatic infections by 94%, research shows – Ynetnews
Study also shows that a week after receiving the second dose, the vaccine is 91-99% efficient in preventing the pathogen from evolving into a serious illness results…

Research conducted by the Clalit Health Fund released Sunday shows that Pfizers coronavirus vaccine is exceptionally effective in preventing infection and severe illness in all age groups, including those aged 70 and over.
The study includes data on some 1.2 million Israelis insured by Clalit, of whom about 600,000 have received both doses of the Pfizers vaccine.
It shows a reduction of 94% in the rate of symptomatic infection and a reduction of 92% in the rate of serious illness among those who…
-
Business16 hours ago
10 ASX shares to buy after the market selloff
-
General19 hours ago
‘We are here for you’: PM to bring help to flood zones
-
Business15 hours ago
$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours ago
We’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening